436 related articles for article (PubMed ID: 17509426)
21. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study.
Recio-Mayoral A; Chaparro M; Prado B; Cózar R; Méndez I; Banerjee D; Kaski JC; Cubero J; Cruz JM
J Am Coll Cardiol; 2007 Mar; 49(12):1283-8. PubMed ID: 17394959
[TBL] [Abstract][Full Text] [Related]
22. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Lee SW; Kim WJ; Kim YH; Park SW; Park DW; Yun SC; Lee JY; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Suh J; Cho YH; Lee NH; Cheong SS; Yoo SY; Lee BK; Lee SG; Hyon MS; Shin WY; Lee SW; Jang JS; Park SJ
Am J Cardiol; 2011 May; 107(10):1447-52. PubMed ID: 21420063
[TBL] [Abstract][Full Text] [Related]
23. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
24. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
25. [Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].
El Mahmoud R; Le Feuvre C; Le Quan Sang KH; Helft G; Beygui F; Batisse JP; Metzger JP
Arch Mal Coeur Vaiss; 2003 Dec; 96(12):1157-61. PubMed ID: 15248440
[TBL] [Abstract][Full Text] [Related]
26. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
[TBL] [Abstract][Full Text] [Related]
27. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
28. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
29. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Spargias K; Adreanides E; Demerouti E; Gkouziouta A; Manginas A; Pavlides G; Voudris V; Cokkinos DV
Circulation; 2009 Nov; 120(18):1793-9. PubMed ID: 19841299
[TBL] [Abstract][Full Text] [Related]
30. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
Marenzi G; Assanelli E; Marana I; Lauri G; Campodonico J; Grazi M; De Metrio M; Galli S; Fabbiocchi F; Montorsi P; Veglia F; Bartorelli AL
N Engl J Med; 2006 Jun; 354(26):2773-82. PubMed ID: 16807414
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of N-acetylcysteine and aminophylline in preventing contrast-induced nephropathy.
Kinbara T; Hayano T; Ohtani N; Furutani Y; Moritani K; Matsuzaki M
J Cardiol; 2010 Mar; 55(2):174-9. PubMed ID: 20206069
[TBL] [Abstract][Full Text] [Related]
32. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.
Marenzi G; Marana I; Lauri G; Assanelli E; Grazi M; Campodonico J; Trabattoni D; Fabbiocchi F; Montorsi P; Bartorelli AL
N Engl J Med; 2003 Oct; 349(14):1333-40. PubMed ID: 14523141
[TBL] [Abstract][Full Text] [Related]
33. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
[TBL] [Abstract][Full Text] [Related]
34. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
35. Renal protection by radical scavenging in cardiac surgery patients.
Fischer UM; Tossios P; Mehlhorn U
Curr Med Res Opin; 2005 Aug; 21(8):1161-4. PubMed ID: 16083524
[TBL] [Abstract][Full Text] [Related]
36. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
37. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
Tepel M; van der Giet M; Schwarzfeld C; Laufer U; Liermann D; Zidek W
N Engl J Med; 2000 Jul; 343(3):180-4. PubMed ID: 10900277
[TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
[TBL] [Abstract][Full Text] [Related]
39. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
40. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]